News of Note—Olympus to study safety, efficacy of upgraded power morcellator

News of note

> Olympus America will conduct a study of 140 hysterectomy patients in an effort to show that its “revamped” power morcellator—which features a bag to keep undetected cancer cells from spreading—is safe and effective. Philadelphia Inquirer story

> CytoSorbents picked up a grant worth more than $700,000 from the U.S. Army Medical Research and Materiel Command to develop new blood-purification treatments to stabilize patients with severe burn injury. Release

Suggested Articles

The FDA has cleared Drawbridge Health’s blood collection device designed to help monitor long-term blood sugar levels in people with diabetes.

FierceMedTech Fierce 15 winner 10x Genomics announced its plans for a $100 million IPO, on the Nasdaq using the symbol TXG.

Belgian devicemaker Miracor Medical received a breakthrough designation from the FDA for its treatment designed to limit the damage of a heart attack.